Vivo Capital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001674712 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value: $366M (100.0% shares, 0.0% debt)

Holdings (23)

— Sagent Pharmaceuticals, Inc. 26.6%

Value $97.3M Shares 6,495,416 Est. Cost $12.17 Unrealized —

ACRS Aclaris therapeutics 21.1%

Value $77.42M Shares 4,191,397 Est. Cost $19.11 Unrealized +3.7%

— Eiger BioPharmaceuticals 8.7%

Value $31.7M Shares 1,599,591 Est. Cost $16.77 Unrealized —

— Nabriva Therapeutics AG 6.5%

Value $23.64M Shares 3,151,700 Est. Cost $8.96 Unrealized —

ASND Ascendis Pharma 6.4%

Value $23.45M Shares 1,766,832 Est. Cost $17.51 Unrealized —

CDXS Codexis, Inc. 6.1%

Value $22.46M Shares 5,573,319 Est. Cost $3.85 Unrealized -5.0%

— Agile Therapeutics, Inc. 4.2%

Value $15.37M Shares 2,019,955 Est. Cost $6.21 Unrealized —

— Advanced Accelerator Applications S.A. 3.8%

Value $13.78M Shares 455,798 Est. Cost $35.02 Unrealized —

— Trevena, Inc. 3.0%

Value $10.89M Shares 1,728,000 Est. Cost $7.67 Unrealized —

— Capnia, Inc. 2.4%

Value $8.65M Shares 7,456,984 Est. Cost $1.19 Unrealized —

— Aimmune Therapeutics, Inc. 2.3%

Value $8.256M Shares 763,009 Est. Cost $10.82 Unrealized —

RGNX Regenxbio Inc. 2.2%

Value $7.924M Shares 990,449 Est. Cost $12.80 Unrealized -13.3%

— Akari Therapeutics Plc 1.9%

Value $7.121M Shares 527,842 Est. Cost $14.00 Unrealized —

— Dynavax Technologies Corporation 1.4%

Value $5.246M Shares 359,828 Est. Cost $19.24 Unrealized —

— ProNAi Therapeutics, Inc. 1.3%

Value $4.852M Shares 2,438,270 Est. Cost $6.74 Unrealized —

— Carbylan Therapeutics 0.8%

Value $2.775M Shares 4,204,562 Est. Cost $0.64 Unrealized —

— Minerva Neurosciences, Inc. 0.6%

Value $2.042M Shares 200,000 Est. Cost $10.21 Unrealized —

— MEI Pharma, Inc. 0.4%

Value $1.498M Shares 1,101,129 Est. Cost $1.26 Unrealized —

— ReVance Therapeutics, Inc. 0.3%

Value $1.052M Shares 77,373 Est. Cost $24.38 Unrealized —

— Ocera Therapeutics, Inc. 0.1%

Value $291K Shares 153,331 Est. Cost $2.94 Unrealized —

— Capnia, Inc. 0.1%

Value $245K Shares 943,858 Est. Cost $0.23 Unrealized —

— Zosano Pharma Corp 0.0%

Value $125K Shares 98,515 Est. Cost $2.30 Unrealized —

— Palatin Technologies, Inc. 0.0%

Value $103K Shares 234,909 Est. Cost $0.54 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Sagent Pharmaceuticals, Inc.	6,495,416	$97.3M	26.6%	$12.17	—	Common	786692103
ACRS	Aclaris therapeutics	4,191,397	$77.42M	21.1%	$19.11	+3.7%	Common	00461U105
—	Eiger BioPharmaceuticals	1,599,591	$31.7M	8.7%	$16.77	—	Common	28249U105
—	Nabriva Therapeutics AG	3,151,700	$23.64M	6.5%	$8.96	—	ADR	62957M104
ASND	Ascendis Pharma	1,766,832	$23.45M	6.4%	$17.51	—	ADR	04351P101
CDXS	Codexis, Inc.	5,573,319	$22.46M	6.1%	$3.85	-5.0%	Common	192005106
—	Agile Therapeutics, Inc.	2,019,955	$15.37M	4.2%	$6.21	—	Common	00847L100
—	Advanced Accelerator Applications S.A.	455,798	$13.78M	3.8%	$35.02	—	Common	00790T100
—	Trevena, Inc.	1,728,000	$10.89M	3.0%	$7.67	—	Common	89532E109
—	Capnia, Inc.	7,456,984	$8.65M	2.4%	$1.19	—	Common	14066L105
—	Aimmune Therapeutics, Inc.	763,009	$8.256M	2.3%	$10.82	—	Common	00900T107
RGNX	Regenxbio Inc.	990,449	$7.924M	2.2%	$12.80	-13.3%	Common	75901B107
—	Akari Therapeutics Plc	527,842	$7.121M	1.9%	$14.00	—	ADR	00972G108
—	Dynavax Technologies Corporation	359,828	$5.246M	1.4%	$19.24	—	Common	268158201
—	ProNAi Therapeutics, Inc.	2,438,270	$4.852M	1.3%	$6.74	—	Common	74346L101
—	Carbylan Therapeutics	4,204,562	$2.775M	0.8%	$0.64	—	Common	141384107
—	Minerva Neurosciences, Inc.	200,000	$2.042M	0.6%	$10.21	—	Common	603380106
—	MEI Pharma, Inc.	1,101,129	$1.498M	0.4%	$1.26	—	Common	55279B202
—	ReVance Therapeutics, Inc.	77,373	$1.052M	0.3%	$24.38	—	Common	761330109
—	Ocera Therapeutics, Inc.	153,331	$291K	0.1%	$2.94	—	Common	67552A108
—	Capnia, Inc.	943,858	$245K	0.1%	$0.23	—	Warrant	14066L113
—	Zosano Pharma Corp	98,515	$125K	0.0%	$2.30	—	Common	98979H103
—	Palatin Technologies, Inc.	234,909	$103K	0.0%	$0.54	—	Common	696077403